MedTrace Logo

A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population

NCT06775665 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-05-30

No results posted yet for this study

Summary

This study is a prospective cohort study aimed at exploring the baseline characteristics and treatment patterns of the Chinese population with hypertrophic cardiomyopathy (HCM) in real-world settings. The objective is to assess the real-world treatment approaches and longitudinal outcomes in this population.

Conditions

  • Hypertrophic Cardiomyopathy (HCM)

Interventions

OTHER

No interventions were applied to the patients.

No interventions were applied to the patients.

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Xiaojie Xie, PhD · Second Affiliated Hospital, Zhejiang University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2031-01-01
Completion
2032-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06775665 on ClinicalTrials.gov